{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T01:54:46Z","timestamp":1794275686799,"version":"4.9.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: CardioOncology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jaccao.2026.05.012","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T22:30:19Z","timestamp":1784068219000},"page":"395-411","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cardiovascular-Kidney-Metabolic Syndrome Staging and Cancer Risk"],"prefix":"10.1016","volume":"8","author":[{"given":"Xixi","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunyao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yugang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruicong","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10440","key":"10.1016\/j.jaccao.2026.05.012_bib1","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/S0140-6736(24)00367-2","article-title":"Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the global burden of disease study 2021","volume":"403","year":"2024","journal-title":"Lancet"},{"issue":"20","key":"10.1016\/j.jaccao.2026.05.012_bib2","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","article-title":"Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.jaccao.2026.05.012_bib3","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12916-025-04013-1","article-title":"Cancer risk subsequent to cardiovascular disease: a prospective population-based study and meta-analysis","volume":"23","author":"Shu","year":"2025","journal-title":"BMC Med"},{"issue":"6","key":"10.1016\/j.jaccao.2026.05.012_bib4","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1053\/j.ajkd.2023.04.014","article-title":"Onconephrology: core curriculum 2023","volume":"82","author":"Yarandi","year":"2023","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"10.1016\/j.jaccao.2026.05.012_bib5","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1002\/oby.23444","article-title":"Metabolic dysfunction and obesity-related cancer: beyond obesity and metabolic syndrome","volume":"30","author":"Karra","year":"2022","journal-title":"Obesity (Silver Spring)"},{"issue":"7982","key":"10.1016\/j.jaccao.2026.05.012_bib6","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41586-023-06592-6","article-title":"Plasma proteomic associations with genetics and health in the UK biobank","volume":"622","author":"Sun","year":"2023","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jaccao.2026.05.012_bib7","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/s12916-022-02449-3","article-title":"Plasma metabolomic profiles of dementia: a prospective study of 110,655 participants in the UK biobank","volume":"20","author":"Zhang","year":"2022","journal-title":"BMC Med"},{"issue":"6","key":"10.1016\/j.jaccao.2026.05.012_bib8","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: the Framingham Heart Study","volume":"117","author":"D\u2019Agostino","year":"2008","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.jaccao.2026.05.012_bib9","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12933-025-02689-6","article-title":"The prognostic significance of stress hyperglycemia ratio in evaluating all-cause and cardiovascular mortality risk among individuals across stages 0-3 of cardiovascular-kidney-metabolic syndrome: evidence from two cohort studies","volume":"24","author":"Tan","year":"2025","journal-title":"Cardiovasc Diabetol"},{"issue":"19","key":"10.1016\/j.jaccao.2026.05.012_bib10","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New Creatinine- and cystatin C-based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.jaccao.2026.05.012_bib11","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/s41577-022-00707-2","article-title":"A guide to antigen processing and presentation","volume":"22","author":"Pishesha","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaccao.2026.05.012_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2026.156508","article-title":"Multi-omics profiling reveals CKM syndrome severity as a gradient risk factor for cancer: a prospective cohort study","volume":"177","author":"Huang","year":"2026","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.jaccao.2026.05.012_bib13","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12944-023-01955-4","article-title":"The association of statin therapy and cancer: a meta-analysis","volume":"22","author":"Chen","year":"2023","journal-title":"Lipids Health Dis"},{"issue":"1","key":"10.1016\/j.jaccao.2026.05.012_bib14","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11154-013-9236-x","article-title":"The microcirculation in adipose tissue inflammation","volume":"14","author":"Scalia","year":"2013","journal-title":"Rev Endocr Metab Disord"},{"issue":"15","key":"10.1016\/j.jaccao.2026.05.012_bib15","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1001\/jama.2026.1114","article-title":"Obesity and cancer: a translational science review","volume":"335","author":"Shen","year":"2026","journal-title":"JAMA"},{"issue":"7728","key":"10.1016\/j.jaccao.2026.05.012_bib16","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/s41586-018-0615-z","article-title":"LILRB4 signalling in leukaemia cells mediates T cell suppression and tumour infiltration","volume":"562","author":"Deng","year":"2018","journal-title":"Nature"},{"issue":"19","key":"10.1016\/j.jaccao.2026.05.012_bib17","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adm7515","article-title":"CD8+ T cell targeting of tumor antigens presented by HLA-E","volume":"10","author":"Iyer","year":"2024","journal-title":"Sci Adv"},{"key":"10.1016\/j.jaccao.2026.05.012_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216985","article-title":"Colorectal cancer-associated fibroblasts inhibit effector T cells via NECTIN2 signaling","volume":"595","author":"Agorku","year":"2024","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jaccao.2026.05.012_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.715234","article-title":"CD8+ T cell exhaustion in cancer","volume":"12","author":"Dolina","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaccao.2026.05.012_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.dnarep.2019.102673","article-title":"Inflammation-induced DNA damage, mutations and cancer","volume":"83","author":"Kay","year":"2019","journal-title":"DNA Repair (Amst)"},{"issue":"2","key":"10.1016\/j.jaccao.2026.05.012_bib21","doi-asserted-by":"crossref","first-page":"188","DOI":"10.12997\/jla.2025.14.2.188","article-title":"HDL-C and hematologic malignancies: a commentary on cohort study","volume":"14","author":"Chung","year":"2025","journal-title":"J Lipid Atheroscler"},{"issue":"7400","key":"10.1016\/j.jaccao.2026.05.012_bib22","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nature11095","article-title":"Inhibitory receptors bind ANGPTLs and support blood stem cells and leukaemia development","volume":"485","author":"Zheng","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jaccao.2026.05.012_bib23","article-title":"Macrophage paired immunoglobulin-like receptor B deficiency promotes peripheral atherosclerosis in apolipoprotein E-deficient mice","volume":"9","author":"Su","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.jaccao.2026.05.012_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.108105","article-title":"New therapeutic horizons for plasma phospholipid transfer protein (PLTP): targeting endotoxemia, infection and sepsis","volume":"236","author":"Gautier","year":"2022","journal-title":"Pharmacol Ther"},{"issue":"12","key":"10.1016\/j.jaccao.2026.05.012_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102637","article-title":"PLTP is a p53 target gene with roles in cancer growth suppression and ferroptosis","volume":"298","author":"Gnanapradeepan","year":"2022","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaccao.2026.05.012_bib26","article-title":"Asialoglycoprotein receptor 1: a multifaceted receptor in the liver and cardiovascular system","volume":"12","author":"Xiao","year":"2025","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"10.1016\/j.jaccao.2026.05.012_bib27","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.intimp.2013.03.012","article-title":"Susceptibility to T cell-mediated liver injury is enhanced in asialoglycoprotein receptor-deficient mice","volume":"16","author":"McVicker","year":"2013","journal-title":"Int Immunopharmacol"},{"issue":"9","key":"10.1016\/j.jaccao.2026.05.012_bib28","article-title":"T cells, triglycerides, and the immune roots of residual cardiovascular risk","volume":"10","author":"Shapiro","year":"2025","journal-title":"JACC Basic Transl Sci"},{"issue":"3","key":"10.1016\/j.jaccao.2026.05.012_bib29","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/labinvest.2011.168","article-title":"Carboxypeptidase-M is regulated by lipids and CSFs in macrophages and dendritic cells and expressed selectively in tissue granulomas and foam cells","volume":"92","author":"Tsakiris","year":"2012","journal-title":"Lab Invest"},{"issue":"1","key":"10.1016\/j.jaccao.2026.05.012_bib30","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1161\/ATVBAHA.117.310208","article-title":"Stable isotope kinetic study of ApoM (Apolipoprotein M)","volume":"38","author":"Croyal","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.jaccao.2026.05.012_bib31","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10528-024-11013-y","article-title":"APOM modulates the glycolysis process in liver cancer cells by controlling the expression and activity of HK2 via the notch pathway","volume":"64","author":"Du","year":"2026","journal-title":"Biochem Genet"},{"key":"10.1016\/j.jaccao.2026.05.012_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2024.148591","article-title":"Unveiling the role of APOM gene in liver cancer: investigating the impact of hsa-miR-4489\/MUC1-mediated ferroptosis on the advancement of hepatocellular carcinoma cells","volume":"925","author":"Liu","year":"2024","journal-title":"Gene"},{"issue":"1","key":"10.1016\/j.jaccao.2026.05.012_bib33","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jid.2017.07.847","article-title":"The role of fibroblast growth factor-binding protein 1 in skin carcinogenesis and inflammation","volume":"138","author":"Schmidt","year":"2018","journal-title":"J Invest Dermatol"},{"issue":"8","key":"10.1016\/j.jaccao.2026.05.012_bib34","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1093\/abbs\/gmab074","article-title":"FGFBP1-mediated crosstalk between fibroblasts and pancreatic cancer cells via FGF22\/FGFR2 promotes invasion and metastasis of pancreatic cancer","volume":"53","author":"Zhang","year":"2021","journal-title":"Acta Biochim Biophys Sin (Shanghai)"}],"container-title":["JACC: CardioOncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666087326002048?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666087326002048?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T23:45:35Z","timestamp":1789515935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666087326002048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2666087326002048"],"URL":"https:\/\/doi.org\/10.1016\/j.jaccao.2026.05.012","relation":{},"ISSN":["2666-0873"],"issn-type":[{"value":"2666-0873","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular-Kidney-Metabolic Syndrome Staging and Cancer Risk","name":"articletitle","label":"Article Title"},{"value":"JACC: CardioOncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaccao.2026.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}